MLNT
Vanguard Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-442,835
| Closed | -$1.69M | – | 4152 |
|
|
2019
Q3 | $1.69M | Buy |
442,835
+380
| +0.1% | +$1.45K | ﹤0.01% | 3505 |
|
|
2019
Q2 | $2.94M | Buy |
442,455
+218,085
| +97% | +$1.45M | ﹤0.01% | 3354 |
|
|
2019
Q1 | $797K | Sell |
224,370
-487,786
| -68% | -$1.73M | ﹤0.01% | 3685 |
|
|
2018
Q4 | $565K | Sell |
712,156
-1,058,609
| -60% | -$840K | ﹤0.01% | 3711 |
|
|
2018
Q3 | $7M | Buy |
1,770,765
+76,253
| +4% | +$301K | ﹤0.01% | 3105 |
|
|
2018
Q2 | $10.8M | Buy |
1,694,512
+873,063
| +106% | +$5.54M | ﹤0.01% | 2865 |
|
|
2018
Q1 | $6.08M | Buy |
821,449
+299,375
| +57% | +$2.22M | ﹤0.01% | 3062 |
|
|
2017
Q4 | $8.25M | Buy |
+522,074
| New | +$8.25M | ﹤0.01% | 2906 |
|